1.Reconstruction of teaching mode of Human Parasitology among rural order-oriented medical students in the context of curriculum ideology and politics
De-ping CAO ; Li-ping JIANG ; Gen CHEN ; Da-yu LI ; Gang MO ; Xiao-hong PENG
Chinese Journal of Schistosomiasis Control 2022;34(2):187-190
To set the cultivation goal with adaptation to rural order-oriented medical students, the teaching mode of Human Parasitology was reformed in the context of curriculum ideological and political education. The new teaching mode not only enables students to harvest medical knowledge during the school education stage, but also plays a guiding role in cultivation of humanistic qualities and professional spirit, which provides a basis for cultivating general practitioners serving for grassroots healthcare.
2.Sensitive Detection of Telomerase Based on Hybridization Chain Reaction-assisted Multiple Signal Amplification
Ya CAO ; Yang Ming KANG ; Hong CHEN ; Ying Ying TANG ; Chang FENG ; Jing ZHAO ; Xi Gen LI
Chinese Journal of Analytical Chemistry 2017;45(12):1903-1908
A new electrochemical method for telomerase activity assay was developed on the basis of hybridization chain reaction ( HCR)-assisted multiple signal amplification, aiming at improving the sensitivity and specificity of telomerase assay. The experiments utilized HeLa cells as original source of the telomerase in the electrochemical studies. The telomerase primer was firstly self-assembled on the surface of gold electrode. The telomerase catalyzed the elongation of the primer, producing the complementary sequences of hairpin probe H1. In this case, HCR was then initiated by interacting with two hairpin probes H1 and H2. Because both H1 and H2 were modified by biotin, horseradish peroxidase could be captured on the electrode surface through the high-affinity interaction between biotin and streptavidin, catalyzing the oxidation of o-phenylenediamine to produce 2,3-diaminophenazine. Therefore, the telomerase assay was realized by tracing the electrochemical signals with differential pulse voltammetry. This electrochemical method was of high efficiency and feasibility for detecting telomerase activity, and could trace the telomerase activity down to 10 cells/mL HeLa cells with a wide linear range. Besides, it could also easily distinguish the target enzyme from the control proteins with high specificity.
3.Health Effect of Forest Bathing Trip on Elderly Patients with Chronic Obstructive Pulmonary Disease.
Bing Bing JIA ; Zhou Xin YANG ; Gen Xiang MAO ; Yuan Dong LYU ; Xiao Lin WEN ; Wei Hong XU ; Xiao Ling LYU ; Yong Bao CAO ; Guo Fu WANG ;
Biomedical and Environmental Sciences 2016;29(3):212-218
Forest bathing trip is a short, leisurely visit to forest. In this study we determined the health effects of forest bathing trip on elderly patients with chronic obstructive pulmonary disease (COPD). The patients were randomly divided into two groups. One group was sent to forest, and the other was sent to an urban area as control. Flow cytometry, ELISA, and profile of mood states (POMS) evaluation were performed. In the forest group, we found a significant decrease of perforin and granzyme B expressions, accompanied by decreased levels of pro-inflammatory cytokines and stress hormones. Meanwhile, the scores in the negative subscales of POMS decreased after forest bathing trip. These results indicate that forest bathing trip has health effect on elderly COPD patients by reducing inflammation and stress level.
Aged
;
Cytokines
;
genetics
;
metabolism
;
Female
;
Forests
;
Gene Expression Regulation
;
physiology
;
Humans
;
Lymphocyte Subsets
;
physiology
;
Male
;
Middle Aged
;
Pulmonary Disease, Chronic Obstructive
;
pathology
;
psychology
;
therapy
;
Recreation
4.Impact of disease activity on postoperative recurrence and complications after bowel resection for Crohn's disease.
Lu-gen ZUO ; Yi LI ; Hong-gang WANG ; Wei-ming ZHU ; Lei CAO ; Wei ZHANG ; Jian-feng GONG ; Ning LI ; Jie-shou LI
Chinese Journal of Surgery 2012;50(8):695-698
OBJECTIVETo determine whether the perioperative disease activity is associated with recurrence and complications after bowel resection for Crohn's disease (CD).
METHODSClinical data of patients underwent bowel resection for CD at the Nanjing General Hospital of Nanjing Military Command from January 2002 to January 2011 was retrospectively analyzed. Postoperative recurrence and complications in patients with active disease were compared with those in patients with remission.
RESULTSA total of 90 patients underwent bowel resection for CD, active disease were seen in 43 patients at the time of surgery, while the rest 47 patients were in remission. The postoperative cumulative endoscopic recurrence rate was 8.5% at 1 year, 27.7% at 2 years and 44.7% at 3 years in the patients with remission, and was 27.9% at 1 year, 37.2% at 2 years and 53.5% at 3 years in patients with active disease. Data indicated the endoscopic recurrence were statistically significant in the first year after surgery (χ² = 4.605, P = 0.032). Additional, the postoperative complication rates in patients with remission (14.9%) was significantly lower than that in patients with active disease (51.2%) (χ² = 6.979, P < 0.001).
CONCLUSIONPatients with active disease at the time of surgery were encountered with early postoperative recurrence and increased complications after intestinal resection for CD.
Adult ; Colon ; surgery ; Crohn Disease ; physiopathology ; surgery ; Female ; Follow-Up Studies ; Humans ; Male ; Postoperative Complications ; Recurrence ; Retrospective Studies ; Young Adult
5.Efficacy and safety of Firebird sirolimus-eluting stent in treatment of complex coronary lesions in Chinese patients: one-year clinical and eight-month angiographic outcomes from the FIREMAN registry.
Yan LI ; Cheng-xiang LI ; Hai-chang WANG ; Bo XU ; Wei-yi FANG ; Jun-bo GE ; Wei-min WANG ; Shu-bin QIAO ; Jack-P CHEN ; Wen-kuang SHEN ; Hong JIANG ; Hong-liang CONG ; Xiao-qun PU ; Yong-wen QIN ; Hui-gen JIN ; Yu CAO ; He HUANG
Chinese Medical Journal 2011;124(6):817-824
BACKGROUNDOff-label application of drug-eluting stents (DES) during percutaneous coronary intervention (PCI) was not uncommon in daily practice, however DES in treating Chinese patients with complex lesion subset was under-investigated. The primary objective of the FIREMAN registry was to evaluate the long term efficacy and safety of the Firebird sirolimus-eluting stent (SES) in treating patients with complex coronary lesions. Here we report the mid-term of one-year clinical outcomes and eight-month angiographic follow-up results of FIREMAN registry.
METHODSThe FIREMAN registry was a prospective multi-center registry, which included 1029 consecutive patients undergoing PCI with Firebird SES implantation between September 2006 and July 2007 in 45 centers in China. The clinical follow-up was designed to be performed at 1, 6, 12, 18, 24, 30 and 36 months post index procedure, and non-mandatory angiographic follow-up at 8 months was planned. One hundred percent site monitoring was conducted.
RESULTSLong lesions (59.2%), multi-vessel disease (50.4%), and small vessel disease (31.6%) were mostly found in angiography. Major adverse cardiac events (MACE) occurred in 51 (5.1%) patients at 1 year clinical follow-up, including cardiac mortality in 6 (0.6%), non-fatal myocardial infarction in 11 (1.1%), and target lesion revascularization in 36 (3.5%) of the patients. Definite and probable stent thrombosis (ST) by Academic Research Consortium (ARC) definition occurred in 12 (1.36%) patients at one-year clinical follow-up. The 8-month binary restenosis rate was 5.7% in-segment and 4.3% in-stent, respectively. Late lumen loss was (0.21 ± 0.40) mm in-segment and (0.23 ± 0.36) mm in-stent, respectively. Furthermore, Cox regression analysis revealed that diabetes, small vessel diameter, and chronic total occlusion were independent predictors of ST.
CONCLUSIONSThe results showed that the Firebird SES was effective and safe in treating Chinese patients with complex coronary lesions and occurrence of ST rate at one-year clinical follow-up was acceptable, however further long-term follow-up was still necessary. (NCT00552656)
Aged ; Angioplasty, Balloon, Coronary ; adverse effects ; methods ; Asian Continental Ancestry Group ; Coronary Angiography ; Coronary Disease ; diagnostic imaging ; therapy ; Drug-Eluting Stents ; adverse effects ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies ; Sirolimus ; therapeutic use ; Treatment Outcome
6.Anti-MDR tumor mechanism of CIP-36, a podophyllotoxin derivative.
Xin MEI ; Yun-gen JIANG ; Jing-jing LÜ ; Ke-zhu WU ; Bo CAO ; Hong CHEN
Acta Pharmaceutica Sinica 2011;46(10):1193-1198
This study is to investigate the antitumor activity of CIP-36 on multidrug resistant human oral squamous carcinoma cell line (KBV200 cells) in vitro and the possible anticancer mechanisms. MTT assay, Hoechst fluorescein stain, RT-PCR and immunohistochemistry were carried out on KBV200 and KB cells. The growth of many tumor cells was obviously inhibited by CIP-36, especially the multidrug resistant cells KBV200. Obvious apoptosis could be observed in the Hoechst 33342 staining experiments. The results of RT-PCR showed that the levels of p53, p21, caspase-3 and bax mRNA increased, and meanwhile the expression of mdr-1 and bcl-2 mRNA decreased in a dose-dependent manner. The data were significantly different from that of vehicle. The expression of P-gp significantly decreased with the increasing dosage of CIP-36 examined by immunohistochemistry. It can be concluded that CIP-36 could change resistance-related genes and proteins to overcome multidrug resistance in the KBV200 cell line.
ATP Binding Cassette Transporter, Sub-Family B
;
ATP-Binding Cassette, Sub-Family B, Member 1
;
genetics
;
metabolism
;
Antineoplastic Agents, Phytogenic
;
administration & dosage
;
pharmacology
;
Apoptosis
;
drug effects
;
Carcinoma, Squamous Cell
;
metabolism
;
pathology
;
Caspase 3
;
genetics
;
metabolism
;
Cell Line, Tumor
;
Cell Proliferation
;
drug effects
;
Dose-Response Relationship, Drug
;
Drug Resistance, Multiple
;
Drug Resistance, Neoplasm
;
Humans
;
KB Cells
;
Mouth Neoplasms
;
metabolism
;
pathology
;
Podophyllotoxin
;
administration & dosage
;
analogs & derivatives
;
pharmacology
;
Proto-Oncogene Proteins c-bcl-2
;
genetics
;
metabolism
;
Proto-Oncogene Proteins p21(ras)
;
genetics
;
metabolism
;
RNA, Messenger
;
metabolism
;
Tumor Suppressor Protein p53
;
genetics
;
metabolism
;
bcl-2-Associated X Protein
;
genetics
;
metabolism
7.Dynamic changes of hippocampai volumes by MRI in rat depression models and their behavior changes before and after antidepressant treatment
Yi-Feng LUO ; Dong-Qing WANG ; Zhi-Hong CAO ; Yan-Ping ZHAO ; Yue-Feng LI ; Guo-Hai LI ; Rui-Gen YIN ; Yan ZHU
Chinese Journal of Neuromedicine 2011;10(9):887-891
Objective To explore the dynamic changes of hippocarnpal volumes by MRI and their behavioral changes in rat depression models before and after antidepressant treatment, and their significance. Methods Based on the evaluation of ethology, 80 SD rats were randomly divided into 3groups: control group (n=10), depression group (n=10), and treatment group (n=60) which was equally divided into 3 subgroups (group A, B and C), given 2 different treatments as self-recovery or Fluoxetine intraperitoneal injection in the 4th, 6th and 8th week. The depression models were established by chronic unpredictable mild stress or isolated feeding for 8 weeks. The body weight and fluid consumption were measured before the antidepressant treatment and every 2 weeks of the treatment, and Morris water maze test was performed and the bilateral hippocampal volumes by high field MRI were measured before and after the antidepressant treatment and every 2 weeks of the treatment. Results The behavioral data indicated that the rat depression models were established successfully and these indexes were changed dynamically. In the 4th week, as compared with those of the control rats, the left hippocampal volumes of depression rats were significantly decreased (P<0.05), while the right ones were not significantly different. In the 6th week, as compared with those of the control rats, the right ones began to significantly decrease the volume (P<0.05), and the left ones kept decreasing. By self-recovery, the ethology changed better in the prophase but worsened in the mid-late phase, and the hippocampal volumes had no significant change. By Fluoxetine treatment, the ethology changed better, and the left hippocampal volumes had significant changes only in the prophase. Conclusion The behavior and hippocampal volumes in rat depression models change dynamically, and after treatment, the ethology and hippocampal volumes change differentially.
8.Treatment of cervical spondylotic myelopathy and radiculopathy by anterior subtotal vertebrectomy and decompression combined graft and internal fixation.
Zhe CHEN ; Lie LIN ; Gen-Hong CAO ; Jian-Min WU
China Journal of Orthopaedics and Traumatology 2009;22(5):394-395
Adult
;
Aged
;
Cervical Vertebrae
;
pathology
;
physiopathology
;
surgery
;
Female
;
Fracture Fixation, Internal
;
adverse effects
;
Humans
;
Intervertebral Disc Displacement
;
pathology
;
Male
;
Middle Aged
;
Radiculopathy
;
Spinal Cord Diseases
;
etiology
;
Spinal Cord Injuries
;
pathology
;
Spinal Diseases
;
pathology
;
Spinal Osteophytosis
;
etiology
;
Transplants
;
adverse effects
9.Magnesium isoglycyrrhizinate in the treatment of chronic liver diseases: a randomized, double-blind, multi-doses, active drug controlled, multi-center study.
Yi-min MAO ; Min-de ZENG ; Yong CHEN ; Cheng-wei CHEN ; Qing-chun FU ; Xiong CAI ; Shan-ming WU ; Ya-gang CHEN ; Ying SUN ; Jun LI ; Yan-hua SUI ; Wei ZHAO ; Lun-gen LU ; Ai-ping CAO ; Hong-zhuan CHEN
Chinese Journal of Hepatology 2009;17(11):847-851
OBJECTIVETo evaluate the efficacy and safety of Magnesium isoglycyrrhizinate in treatment of chronic liver diseases.
METHODSIt is a randomized, double-blind, multi-doses, active drug controlled, multi-center study. 480 proper patients were randomly divided into group A (180 patients), group B (180 patients) or group C (120 patients). Patients in group A received magnesium isoglycyrrhizinate 100 mg once daily. Patients in group B received magnesium isoglycyrrhizinate 150 mg once daily. Patients in group C received compound glycyrrhizin 120 mg once daily. The treatment course was 4 weeks. Patients were followed up 2 weeks after the treatment. Patients visited once every 2 weeks. Clinical symptoms, ALT, AST were evaluated in all the patients before treatment, at week 2, at week 4 and at 2 weeks later after treatment. The other liver function test was done before treatment and at week 4.
RESULTS412 patients completed the study according to the protocol,152 in group A, 160 in group B and 100 in group C. ALT and AST level were significantly decreased in all groups at week 2 and week 4 (P < 0.05). The degree of ALT decrease is greater in group B than in group C at week 2 (P < 0.01). The degree of ALT decrease was not significant different among three groups at week 4 (P > 0.05). The rates of ALT improvement at week 4 in group A, B, C were 92.59%, 91.76%, 88.29%, respectively (P > 0.05). The rates of symptoms improvement at week 4 in group A, B, C were 90.41%, 89.86%, 86.46% and 72.22%, 73.53%, 68.47%, respectively (P > 0.05). No relapse were found in all three groups after treatment. The rate of adverse event in three groups was similar (P > 0.05).
CONCLUSIONMagnesium isoglycyrrhizinate is an effective and safe treatment for chronic liver diseases.
Alanine Transaminase ; blood ; Anti-Inflammatory Agents ; adverse effects ; pharmacology ; therapeutic use ; Aspartate Aminotransferases ; blood ; Chronic Disease ; Double-Blind Method ; Fatty Liver ; blood ; drug therapy ; Female ; Glycyrrhizic Acid ; adverse effects ; pharmacology ; therapeutic use ; Humans ; Injections, Intravenous ; Liver ; drug effects ; pathology ; Liver Diseases ; blood ; drug therapy ; Liver Diseases, Alcoholic ; blood ; drug therapy ; Male ; Saponins ; adverse effects ; pharmacology ; therapeutic use ; Triterpenes ; adverse effects ; pharmacology ; therapeutic use
10.Genetic polymorphisms of alcohol dehydrogenase-2 and aldehyde dehydrogenase-2 associated with the susceptibility on esophageal cancer
Jian-Hua DING ; Su-Ping LI ; Hai-Xia CAO ; Jian-Zhong WU ; Chang-Ming GAO ; Ping SU ; Yan-Ting LIU ; Jian-Nong ZHOU ; Jun CHANG ; Gen-Hong YAO
Chinese Journal of Epidemiology 2009;30(5):455-458
Objective To evaluate the impact of alcohol dehydrogenase-2 (ADH2) and aldehyde dehydrogenase-2 (ALDH2) polymorphisms on the susceptibility of esophageal cancer. Methods A case-control study including 221 cases of esophageal cancer and 191 controls was carried out in Taixing city of Jiangsu province. ADH2 and ALDH2 genotypes were tested by PCR and denaturing high -- performance liquid chromatography (DHPLC). Results (1) Compared with ALDH2 G/G carriers, ALDH2 A/A (OR=5.69, 95%CI: 2.51-12.18) and ALDH2 G/A (OR=1.70, 95%CI: 1.08-2.68) carriers showed a significantly elevated risk of developing esophageal cancer, especially among alcohol drinkers with ALDH2 A/A (OR=8.63,95% CI: 2.07-35.95). (2) Statistical relation was not found between ADH2 genotypes and the risk of esophageal cancer, with regard to the status of alcohol consumption. (3) Whether subjects with whatever ADH2 genotype, ALDH2 G/A or A/A carriers was found to have significantly increased the risk of developing esophageal cancer, with ALDH2 A/A carriers appeared having higher esophageal cancer risk than those ALDH2 G/A carriers. (4)Compared those non-drinkers with both ALDH2 G/G and ADH2 A/A , drinkers with ALDH2 G/A or A/A and ADH2 C,/A or G/G genotypes showed a significantly elevated risk of developing esophageal cancer (OR=8.36, 95% CI: 2.98-23.46). Conclusion These results revealed that it was not ADH2 but ALDH2 polymorphisms and drinking alcohol had a significant interaction with the development of esophageal cancer, suggesting that in order to help lowering the risk of esophageal cancer, individuals who are carrying ALDH2 A/A or G/A genotypes should be encouraged to reduce their consumption of alcohols.

Result Analysis
Print
Save
E-mail